National, Phase IV, Multicentric, Open Label, Comparative Study to Evaluate the Efficacy and Safety of Insulin Glargine Plus Glulisine and Sliding Scale Plus Glulisine in Hospitalized Patients With Diabetes Metabolism Type II Under Enteral Nutrition.
Phase of Trial: Phase IV
Latest Information Update: 26 Mar 2012
At a glance
- Drugs Insulin glargine; Insulin glulisine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Sanofi
- 26 Mar 2012 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 04 Apr 2011 Actual end date (1 Feb 2011) added as reported by ClinicalTrials.gov.
- 04 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.